272 related articles for article (PubMed ID: 27020242)
1. Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways.
Cheng S; Zhang X; Huang N; Qiu Q; Jin Y; Jiang D
BMC Cancer; 2016 Mar; 16():253. PubMed ID: 27020242
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Calcium-Binding Protein S100A9 Inhibits Hypopharyngeal Cancer Cell Proliferation and Invasion Ability Through Inactivation of NF-κB Signaling.
Wu P; Quan H; Kang J; He J; Luo S; Xie C; Xu J; Tang Y; Zhao S
Oncol Res; 2017 Nov; 25(9):1479-1488. PubMed ID: 28276321
[TBL] [Abstract][Full Text] [Related]
3. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
4. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q
Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
Liu Y; Luo G; He D
Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
[TBL] [Abstract][Full Text] [Related]
6. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway.
Cheng DD; Zhu B; Li SJ; Yuan T; Yang QC; Fan CY
J Cancer; 2017; 8(14):2720-2728. PubMed ID: 28928861
[No Abstract] [Full Text] [Related]
10. Bispecific antibody suppresses osteosarcoma aggressiveness through regulation of NF-κB signaling pathway.
Yu GH; Li AM; Li X; Yang Z; Peng H
Tumour Biol; 2017 Jun; 39(6):1010428317705572. PubMed ID: 28631557
[TBL] [Abstract][Full Text] [Related]
11. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
12. Activation of TNF-α/NF-κB axis enhances CRL4B
Zhang C; Chen B; Jiang K; Lao L; Shen H; Chen Z
Mol Oncol; 2018 Apr; 12(4):476-494. PubMed ID: 29377600
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
Lin ML; Lu YC; Chung JG; Wang SG; Lin HT; Kang SE; Tang CH; Ko JL; Chen SS
Mol Carcinog; 2010 Sep; 49(9):783-97. PubMed ID: 20607722
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling.
He JY; Xi WH; Zhu LB; Long XH; Chen XY; Liu JM; Luo QF; Zhu XP; Liu ZL
Tumour Biol; 2015 May; 36(5):3895-902. PubMed ID: 25874486
[TBL] [Abstract][Full Text] [Related]
17. Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Xiong W; Zhou Q; Liu G; Liu XS; Li XY
Tumour Biol; 2017 May; 39(5):1010428317697566. PubMed ID: 28474998
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRAF4 expression suppresses osteosarcoma cell growth in vitro and in vivo.
Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
Int J Mol Med; 2014 Dec; 34(6):1655-60. PubMed ID: 25270078
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
20. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
